Protagonist Therapeutics, Inc (PTGX) Net margin 2017–2025
Protagonist Therapeutics, Inc (PTGX) net profit margin by fiscal year — reported net income divided by reported revenue.
-282.8%FY2025 · since FY2017: -184.2% → -282.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -282.8% | -346.2 pp |
| FY2024 | 63.3% | +194.9 pp |
| FY2023 | -131.6% | +347.7 pp |
| FY2022 | -479.3% | -20.3 pp |
| FY2021 | -458.9% | -227.9 pp |
| FY2020 | -231.1% | +33183.2 pp |
| FY2019 | -33414.3% | -33288.4 pp |
| FY2018 | -125.9% | +58.3 pp |
| FY2017 | -184.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice